Compare

Shattuck Labs, Inc. vs 60 Degrees Pharmaceuticals, Inc. vs Dare Bioscience, Inc. vs China SXT Pharmaceuticals, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearShattuck Labs, Inc.
STTK
60 Degrees Pharmaceuticals, Inc.
SXTP
Dare Bioscience, Inc.
DARE
China SXT Pharmaceuticals, Inc.
SXTC
Year ended2025-12-312025-12-312025-12-312026-03-31
Revenue$1.00M$1.01M$1.03M$1.14M
Revenue growth (YoY)-82.5%+65.5%n/m-34.6%
Gross marginn/a22.3%71.3% (computed)21.9%
Operating marginn/m-771.6%n/m-625.9%
Net marginn/m-732.5%n/m-545.2%
Net income-$48.81M-$7.37M-$13.40M-$6.21M
EPS (Diluted)-$0.70-$11.73-$1.20-$9.13
Operating cash flow-$39.88M-$6.85M-$9.90M-$4.02M
Free cash flow-$39.95M-$6.99M-$10.29Mn/a
Cash & equivalents$54.19M$1.51M$24.71M$28.18M
Total assets$91.03M$5.37M$32.47M$34.75M
Total liabilities$8.64M$1.99M$29.63M$5.05M
Shareholders' equity$82.39M$3.46M$2.84M$29.71M
Return on year-end equity-59.2%-212.7%-471.4%-20.9%
Shares outstanding63.28M1.16M14.50Mn/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearShattuck Labs, Inc.60 Degrees Pharmaceuticals, Inc.Dare Bioscience, Inc.China SXT Pharmaceuticals, Inc.
Latest$1.00M
Ended 2025-12-31
$1.01M
Ended 2025-12-31
$1.03M
Ended 2025-12-31
$1.14M
Ended 2026-03-31
1 year earlier$5.72M
Ended 2024-12-31
$607.6K
Ended 2024-12-31
$9.8K
Ended 2024-12-31
$1.74M
Ended 2025-03-31
2 years earlier$1.66M
Ended 2023-12-31
$253.6K
Ended 2023-12-31
$2.81M
Ended 2023-12-31
$1.93M
Ended 2024-03-31
3 years earlier$652.0K
Ended 2022-12-31
$223.2K
Ended 2022-12-31
$10.00M
Ended 2022-12-31
$1.97M
Ended 2023-03-31
4 years earlier$30.02M
Ended 2021-12-31
n/a$0
Ended 2021-12-31
$2.60M
Ended 2022-03-31